DIRS.INFO The most relevant business & tech news

☆ China coast guard detains Taiwanese fishing boat near frontline islands, Taiwan says
▼ + stars: | 2024-07-03 | by ( Eric Cheung | Nectar Gan | ) edition.cnn.com time to read: +3 min

Taipei, Taiwan CNN —China’s coast guard detained a Taiwanese fishing vessel and its five-member crew near the mainland’s southeast coast on Tuesday night, according to Taiwan authorities, in the latest flare-up of tensions in waters around a group of frontline islands controlled by Taipei. In a statement, Taiwan’s coast guard said the fishing boat, Tachinman 88, was intercepted by two Chinese coast guard vessels near the Kinmen islands, which lie just miles from the Chinese city of Xiamen. China coast guard officers boarded the fishing boat and then escorted it to a nearby Chinese port, the statement said, adding that three Taiwan coast guard vessels answered a call for help but retreated to avoid conflict when they were outnumbered by their Chinese counterparts. The Taiwan coast guard demanded the immediate release of the boat and crew members. In late February, Chinese coast guard officers intercepted and boarded a Taiwanese tourist boat for inspection, an unprecedented move that startled Taiwanese passengers.

Persons: Hsieh Ching, China’s, Lai Ching, ”, Chen Yu, jen Organizations: Taiwan CNN, Taiwan’s Coast Guard Administration, Coast Guard Administration, Communist Party, Democratic Progressive Party, Kuomintang, CNN, Taiwan’s Ministry, Agriculture Locations: Taipei, Taiwan, Xiamen, China, Beijing, Kinmen, China’s

☆ American Power Shift: CEOs, Average Employees Live in Different Cities
▼ + stars: | 2024-06-12 | by ( Ned Resnikoff | ) www.businessinsider.com time to read: +9 min

Given this truism, it's no wonder that the populations of America's so-called superstar cities have stagnated while the Sun Belt's metropolitan areas have boomed. The COVID-era transition to more remote work accelerated this process of "domestic offshoring," a recent study by the workforce-analytics company ADP found. Domestic offshoring regionally segregates middle- and working-class employees from their employers, making it far more difficult for the former group to advance professionally. Domestic offshoring threatens to lock in these effects, potentially costing the country trillions of dollars in forgone wealth creation. But if domestic offshoring persists, fewer of the city's other residents will be middle-class professionals; those people will tend to congregate in domestic-offshoring sites.

Persons: Austin, Chang, Tai Hsieh, Enrico Moretti, Ned Resnikoff Organizations: Sun, Orlando, America, —, Companies, Workers Locations: California, New York, Los Angeles, San Francisco, Jacksonville , Florida, Raleigh , North Carolina, Texas , Arizona, Florida, Austin, Raleigh, Charlotte, North Carolina, America's, Nashville, Bay, Tennessee, New York City, San Francisco and New York

☆ A corner of the cancer therapy market is heating up—Here are the names investors need to know
▼ + stars: | 2024-05-23 | by ( Michelle Fox | ) www.cnbc.com time to read: +8 min

A $25 billion market Meanwhile, RBC Capital Markets sees a $25 billion market opportunity for the space. A name Jones likes is Perspective Therapeutics , which he rates outperform. CATX 1Y mountain Perspective Therapeutics year to date Cantor Fitzgerald is also bullish on the name. So it's really an ideal profile," said Piper Sandler analyst Edward Tenthoff, who doesn't cover Perspective Therapeutics. Then there is Lantheus Holdings , which calls itself a radiopharmaceutical-focused company and has a $5.6 billion market cap.

Persons: There's, Eli Lilly, Myers, Jefferies, Andrew Tsai, radiopharma, Oppenheimer, Jeff Jones, FactSet, William Blair, Read, — it's, Andy Hsieh, Gregory Renza, Jones, Cantor Fitzgerald, Louise Chen, it's, Piper Sandler, Edward Tenthoff, Dan Lyons, Janus Henderson, Lantheus, Roanna Ruiz Organizations: Novartis, pharma, Mariana Oncology, Myers Squibb, AstraZeneca, Fusion Pharmaceuticals, RBC Capital Markets, TRT, Therapeutics, Alpha, Janus, Janus Henderson Investors, Lantheus Holdings, Lantheus, Leerink, ~$ Locations: Biopharma, Bristol, Mariana, radiopharma, New Jersey

☆ Executives at these companies, including Disney, are scooping up stock amid the market comeback
▼ + stars: | 2024-05-14 | by ( Jesse Pound | In Jesse-Pound | ) www.cnbc.com time to read: +2 min

Corporate executives and board members have made several notable buys of their own stock in the opening days of May, including a big Wall Street name buying shares of Walt Disney . Director James Gorman bought 20,000 shares of the entertainment company for $2.1 million on May 8, according to securities filings and VerityData. Gorman's buy is something of an outlier among Disney executives this year, as two executive vice presidents have made small sales in 2024. Several other Macerich insiders have also bought shares in May. Pegram also bought shares in March.

Persons: Walt Disney, James Gorman, Gorman, Morgan Stanley, Gorman's, Ali John Mirshekari, Martha Sullivan's, Jackson Hsieh, Macerich, Michael Pegram's, Pegram, —, Nick Wells Organizations: Walt, Disney, Sensata, MAC, Caesars Entertainment, Caesars Locations: America

☆ She Wanted to Help Strangers. Would They Take Her Up on It?
▼ + stars: | 2024-05-09 | by ( James Yeh | ) www.nytimes.com time to read: +1 min

She was dressed rather noticeably, and perhaps slightly humiliatingly, in a red jumpsuit and a white sandwich board she had assembled the night before, writing the words “FREE HELP” in red marker. It was the first day of a project by Ms. Giaever, 34, a filmmaker and radio producer whose work, inspired by performance artists like Sophie Calle and Tehching Hsieh, often involves personal journeys and interactions with strangers. Would the strangers in this supposedly cold and impersonal city accept her help? And if they did, how much could she really help them? Over the course of the four days I spent with Ms. Giaever, things would get more complicated.

Persons: Bianca Giaever, Giaever, Sophie Calle, Tehching Hsieh, ” Organizations: Yorkers

☆ Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
▼ + stars: | 2024-03-03 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +8 min

In this article VKTX Follow your favorite stocks CREATE FREE ACCOUNTCr | Istock | Getty ImagesBiotech company Viking Therapeutics has emerged as a strong potential entrant — or takeover target — in the budding weight loss drug market. Their treatments sparked the weight loss drug industry gold rush over the past year despite their hefty price tags and barriers to insurance coverage. It's too early to say whether Viking's drug could have an edge over existing or developing weight loss treatments. The pharmaceutical giant could also launch a slate of other weight loss treatments over the next few years that may have advantages over Zepbound, whether they offer more weight loss or convenience. That could give Viking the commercial and manufacturing capabilities needed to compete in the weight loss drug market.

Persons: Eli Lilly, Eli Lilly's Zepbound, Viking, Goldman Sachs, Eli Lilly’s, Brendan Mcdermid, GLP, Brian Lian, William Blair, Andy Hsieh, Hsieh, Eli Lilly's, Jefferies, Akash Tewari, doesn't, Mike Segar, Lian, William Blair's Hsieh, Oppenheimer, Jay Olson Organizations: Getty Images Biotech, Viking Therapeutics, Novo Nordisk, Reuters, Viking, Novo, U.S . Food, Drug Administration, Company, Deutsche Bank, CNBC Locations: New York City, Branchburg , New Jersey

☆ Viking stock doubled Tuesday. Here's where the next moves in the obesity space could come from
▼ + stars: | 2024-02-27 | by ( Christina Cheddar Berk | In | ) www.cnbc.com time to read: +8 min

VKTX YTD mountain Viking shares year to date Then, Viking shares more than doubled in trading on Tuesday, putting the stock on pace to report a more than 300% year-to-date gain, after the company said its GLP-1/GIP receptor agonist VK2735 hit all its primary goals in a phase 2 clinical trial. The Tema Cardiovascular and Metabolic ETF (HRTS) , which is up 12% year to date, owns Novo, Lilly and Viking. Still early days Some analysts and investors admit it is still very early days for obesity treatment and many questions remain to be answered. "We continue to expect above consensus growth in the space, as we are bullish on adoption from payers and broader obesity uptake," Meacham wrote. For obesity only, Lilly has already gained a 38% share, despite only being in the market for 13 weeks, he said.

Persons: Eli Lilly, Geoff Meacham, Meacham, Lilly, Yuri Khodjamirian, Khodjamirian, Jeff Jonas, Becton Dickinson, Novo, BofA's Meacham, What's, Tema's, it's, Gabelli's Jonas, he's, William Blair, Andy Hsieh, Hsieh Organizations: Novo Nordisk, Bank of America, Centers for Disease Control, Zealand Pharma, Viking Therapeutics, Zealand, Food and Drug Administration, Novo, Metabolic, Therapeutics, Pharmaceuticals, Rock, AstraZeneca, Roche, Gabelli Funds, FDA, Viking, Merck, Pfizer Locations: U.S, Tema, Novo Nordisk's, GLP, Lilly

MELBOURNE, Australia (AP) — Veteran Indian player Rohan Bopanna and his Australian partner Matthew Ebden have advanced to their second consecutive Grand Slam men's doubles final. Bopanna and Ebden, now ranked second in men's doubles, lost to Rajeev Ram and Joe Salisbury in the U.S. Open final last September. Tournament officials said Thursday that Ebden and Bopanna, at combined ages of 79 years, will become the oldest No. In the first women's doubles semifinal, Hsieh Su-wei of Taiwan and Elise Mertens of Belgium, the No. The other women's doubles semifinal will be played Friday ahead of Sunday's final.

Persons: Rohan Bopanna, Matthew Ebden, Zhang Zhizhen, Tomas Machac, Rod Laver, Rajeev Ram, Joe Salisbury, Zhang, Machac, ” Ebden, “ I’ve, We’ve, Ebden, Simone Bolelli, Andrea Vavassori, Yannick Hanfmann, Dominik Koepfer, Hsieh Su, Elise Mertens, Belgium, Storm Hunter, Australia, Katerina Siniakova, Coco Gauff, Aryna Sabalenka, Daryna Yastremska, Zheng Qinwen Organizations: — Veteran, U.S Locations: MELBOURNE, Australia, China, Czech Republic, Germany, Taiwan

☆ Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
▼ + stars: | 2024-01-14 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

SAN FRANCISCO — An established but promising group of cancer drugs was a red-hot market in 2023, and more companies could look to the treatments to fuel growth in the year ahead. Interest in the drugs will only continue this year, as some analysts expect more dealmaking and advancements in ADCs currently in development. The drugs also have potential to draw huge profits: ADCs could account for $31 billion of the $375 billion worldwide cancer market in 2028, according to estimates from the drug market research firm Evaluate. The market for those drugs in 2023 was estimated to be worth around $9.7 billion, another report from research firm MarketsandMarkets said. Everyone wants to gain exposure to [ADCs] and basically make it a cornerstone of their entire corporate strategy," Hsieh told CNBC.

Persons: FRANCISCO —, Johnson, Andy Hsieh, William Blair, MarketsandMarkets, Hsieh Organizations: FRANCISCO, JPMorgan Healthcare Conference, ADC, Pfizer, Merck, William Blair & Company, CNBC Locations: San Francisco, ADCs, drugmakers, Asia

☆ US-China cooperation creates a 'win-win' for the auto industry: Hesai Technology
▼ + stars: | 2023-11-15 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailUS-China cooperation creates a 'win-win' for the auto industry: Hesai TechnologyLouis Hsieh, CFO of Hesai Technology, a Shanghai-based maker of laser sensors, says he hopes for greater US-China cooperation. He discusses the benefits of AI for the automotive industry.

Persons: Hesai Technology Louis Hsieh Organizations: Hesai Technology Locations: China, Shanghai

☆ The Las Vegas Area’s Most Expensive Home Is Up for Sale Again
▼ + stars: | 2023-11-10 | by ( Sarah Paynter | ) www.wsj.com time to read: 1 min

Be the first to know about the biggest and best luxury home sales and listings by signing up for our Mansion Deals email alert. Just two years after setting a Las Vegas-area record with a $25 million home purchase, loanDepot founder Anthony Hsieh is putting the property back on the market for $34 million.

Persons: Anthony Hsieh Locations: Las Vegas

☆ The Las Vegas Area’s Most Expensive Home Is Up For Sale Again
▼ + stars: | 2023-11-07 | by ( Sarah Paynter | ) www.wsj.com time to read: 1 min

Persons: Anthony Hsieh Locations: Las Vegas

Angel Au-YeungAngel Au-Yeung is a reporter in The Wall Street Journal's finance bureau. Her stories explore how some of the largest financial institutions and investors influence corporate America and Main Street. She joined the Journal from Forbes, where she was a staff writer. During her five years at Forbes, she won two Society for Advancing Business Editing and Writing awards. She is co-writing a biography about Tony Hsieh, which will be published by Henry Holt & Co., an imprint of Macmillan Publishers.

Persons: Angel, Angel Au, Tony Hsieh, Henry Holt Organizations: Forbes, Society, Henry Holt & Co, Macmillan Publishers Locations: America, Russian

☆ Lilly eyes targeted cancer therapies with $1.4 billion Point Biopharma deal
▼ + stars: | 2023-10-03 | by ( Bhanvi Satija | Leroy | ) www.reuters.com time to read: +2 min

(Reuters) -Eli Lilly and Co will buy Point Biopharma Global for $1.4 billion, the companies said on Tuesday, gaining access to experimental therapies that enable precise targeting of cancer. Lilly has offered $12.50 per Point Biopharma share held, representing a premium of about 87% to the stock’s last close. Shares of Indiana-based Point Biopharma soared 85%, while Lilly’s stock was down about 3%. Point Biopharma has licensed both its late-stage experimental therapies to Lantheus Holdings since 2022. A Lantheus spokesperson said the company’s commercial rights remain intact and its collaboration with Point Biopharma is progressing in line with expectations.

Persons: Eli Lilly, Mike Segar, Lilly, ”, William Blair, Andy Hsieh Organizations: Reuters, Company, REUTERS, Dice Therapeutics, Novartis, Lantheus Holdings Locations: Branchburg , New Jersey, Indiana, Biopharma’s Indianapolis, PNT2002, U.S

☆ Kirsten Grind — Enterprise Reporter at The Wall Street Journal
▼ + stars: | 2023-09-22 | by ( Kirsten Grind | ) www.wsj.com time to read: 1 min

Kirsten GrindKirsten Grind is an enterprise reporter for The Wall Street Journal, where she has worked since 2012. She focuses on technology companies and executives, covering issues ranging from sexual harassment allegations to data privacy issues. She is the co-author of the recently released book “Happy At Any Cost: The Revolutionary Vision and Fatal Quest of Zappos CEO Tony Hsieh,” from Simon & Schuster. Her first book, “The Lost Bank,” about the collapse of Washington Mutual, was named the best investigative book of 2012 by the Investigative Reporters & Editors association. She lives in the San Francisco Bay area.

Persons: Kirsten, Gerald Loeb, Tony Hsieh, ”, Simon, Simon & Schuster Organizations: Wall Street, Simon &, Lost Bank, ”, Washington Mutual, Investigative Locations: San Francisco Bay

☆ Katherine Sayre — Reporter at The Wall Street Journal
▼ + stars: | 2023-09-12 | by ( Katherine Sayre | ) www.wsj.com time to read: 1 min

Katherine SayreKatherine Sayre is a reporter covering the gambling industry in The Wall Street Journal’s entertainment bureau in Los Angeles. Her stories explore the bustling casinos on the Las Vegas Strip and how sports betting is changing media, sports leagues and sports fandom in America. Katherine is the co-author with Journal colleague Kirsten Grind of “Happy at Any Cost: The Revolutionary Vision and Fatal Quest of Zappos CEO Tony Hsieh,” published by Simon & Schuster in March 2022. Before joining the Journal, Katherine was a lead investigative reporter for the Times-Picayune in New Orleans. She grew up in Brownwood, Texas, and graduated from the University of Texas and Northwestern University.

Persons: Katherine Sayre Katherine Sayre, Katherine, Kirsten Grind, Tony Hsieh, ”, Simon, Simon & Schuster Organizations: Las, Simon &, Times, University of Texas, Northwestern University Locations: Los Angeles, America, New Orleans, Brownwood , Texas

☆ WTA Finals to be held in Cancun
▼ + stars: | 2023-09-07 | by ( ) www.reuters.com time to read: +3 min

[1/2] Tennis - WTA Tour Finals - Panamerican Tennis Center, Guadalajara, Mexico - November 17, 2021 The WTA Finals Martina Navratilova Trophy is seen after Czech Republic's Barbora Krejcikova and Katerina Siniakova won their final doubles match against Taiwan's Hsieh Su-wei and Belgium's Elise Mertens Acquire Licensing Rights Read moreSept 7 (Reuters) - The 2023 edition of the WTA Finals will be held in Cancun, Mexico from Oct. 29-Nov. 5 under a one-year agreement, the women's tennis body announced on Thursday, ending speculation that this year's event could be held in Saudi Arabia. "This edition of the WTA Finals will provide a fantastic experience for players and fans alike, offer a fitting finale for the 2023 WTA Tour, and enable us to continue building a strong future for women's tennis," said Steve Simon, WTA Chairman and CEO. After the men's ATP Tour announced last month that the Next Gen Finals would be held in Jeddah from 2023 to 2027, social media had been awash with rumours that the WTA Finals could also be headed to Saudi Arabia. The WTA Finals will end two days before the beginning of the Billie Jean King Cup finals in Seville. "The WTA weighed a number of competitive bids through a thorough process, in close consultation with the WTA Players’ Council," the WTA said on Thursday.

Persons: Martina Navratilova, Krejcikova, Katerina Siniakova, Taiwan's Hsieh Su, Belgium's Elise Mertens, Steve Simon, Simon, Chris Evert, Peng Shuai, Billie Jean King, Iga Swiatek, Aadi Nair, Toby Davis Organizations: Tennis Center, WTA, ATP, ESPN, Billie Jean King Cup, WTA Players ’, Thomson Locations: Guadalajara, Mexico, Czech, Cancun, Saudi Arabia, Jeddah, Saudi, Tunisian, Shenzhen, China, Fort Worth , United States, Los Angeles, Madrid, Doha, Istanbul, Singapore, Seville, Bengaluru

☆ Years after #MeToo first swept the world, Taiwan races to respond
▼ + stars: | 2023-07-28 | by ( Sarah Wu | ) www.reuters.com time to read: +5 min

TAIPEI, July 28 (Reuters) - Six years after the #MeToo movement rose to global prominence and toppled powerful perpetrators of sexual abuse, Taiwan is racing to reform laws and provide training and support as it reckons with its own wave of complaints. The drama mirrored reality two months ago when an allegation of sexual abuse surfaced that was linked to Taiwan's ruling party. Her criticism of the then-head of the Democratic Progressive Party's women's affairs department for dismissing her complaint went viral. COMPANIES RESPOND TOOBusinesses are also responding by investigating complaints and training staff in preventing abuse. Hsieh said he hoped exposure to the movement at a young age would help his daughters develop a sense of equality.

Persons: Lai Pei, Lai, Chen Chien, jou, Tsai Ing, Chen Chao, Lee Yen, jong, Lee, Peng Yen, Liu Jung, jen, Liu, Yu Mei, Yu, Johnson Hsieh, Hsieh, Sarah Wu, John Geddie, Robert Birsel Organizations: Netflix, Facebook, Democratic Progressive, National Taiwan University, Women's Foundation, Reuters, Taiwan Bar Association, Thomson Locations: TAIPEI, Taiwan, Asia, Taipei

☆ Strycova wins doubles title with Hsieh on her farewell at Wimbledon
▼ + stars: | 2023-07-16 | by ( ) www.reuters.com time to read: +1 min

LONDON, July 16 (Reuters) - Hsieh Su-wei and Barbora Strycova captured their second Wimbledon women's doubles title in four years by defeating third seeds Storm Hunter and Elise Mertens 7-5 6-4 under a closed Centre Court roof on Sunday. The Taiwan-Czech 37-year-olds, who also triumphed together in 2019, sealed the first set after Australian Hunter slapped a forehand into the net. "I couldn't ask for a better finish," said Strycova, who reached the Wimbledon singles semi-finals in 2019. The doubles title was Hsieh's fourth at Wimbledon, having also teamed up with Belgian Mertens in 2021 and China's Peng Shuai in 2013. Reporting by Pritha Sarkar, editing by Ken FerrisOur Standards: The Thomson Reuters Trust Principles.

Persons: Hsieh, Strycova, Storm Hunter, Elise Mertens, Hunter, Taiwan's Hsieh Su, Belgium's Elise Mertens, Australia's, Belgian Mertens, China's Peng Shuai, Pritha Sarkar, Ken Ferris Organizations: Wimbledon, Lawn Tennis, Croquet Club, Thomson Locations: Taiwan, Czech, London, Britain, U.S

It's the match-up we were all dreaming of, and you can enjoy a free Wimbledon final live stream with us today too. Wherever you are in the world, we can help show you where to watch Djokovic vs Alcaraz online for free. If you're not in the UK, you can still watch for free using a VPN (virtual private network) - otherwise, geo-blocking will stop you from watching the Djokovic vs. Alcaraz live stream today. Head online to the iPlayer, and you can live stream Djokovic vs. Alcaraz for free today. How to watch the Wimbledon women's doubles finalYou can get even more tennis today as the women's doubles final will follow the Djokovic vs. Alcaraz final on Centre Court.

Persons: Djokovic, It's, aren't, ExpressVPN, Elise Mertens, Storm Sanders, Strycova, Hsieh Su Organizations: All England Club, Wimbledon, BBC, BBC1, USA ABC, ESPN, Tennis Channel, ESPN Plus, Disney, Hulu, Subscription Locations: Australia, 9Now, USA, Belgium, Czech Republic, Taiwan

☆ Grand Slam King Djokovic wins 23rd crown by conquering Ruud at French Open
▼ + stars: | 2023-06-11 | by ( Shrivathsa Sridhar | ) www.reuters.com time to read: +4 min

On an historic day on Court Philippe Chatrier, Djokovic won his 21st consecutive Grand Slam tournament match to become the only man to capture each of the four majors - Australian Open, French Open, Wimbledon and U.S. Open - at least three times. "Obviously a Grand Slam is a Grand Slam," Djokovic said. "It's no coincidence that I won the 23rd Grand Slam here in Paris, because this tournament was really in my entire career the toughest to win. Victory meant Djokovic has won the first two Grand Slams in a year for a third time after similar runs in 2016 and 2021. "Another day, another record and another day you rewrite tennis history," Ruud said, addressing a beaming Djokovic.

Persons: Novak Djokovic, Casper Ruud, Rafa Nadal, of Clay, Roland Garros, Philippe Chatrier, Djokovic, it's, Nadal, Carlos Alcaraz, Ruud, Alcaraz, Kylian, Zlatan Ibrahimovic, Ruud volleyed, ranted, I'm, Taiwan's Hsieh Su, China's Wang Xinyu, Taylor Townsend, Leylah Fernandez, Julien Pretot, Toby Davis Organizations: Wimbledon, Serbian, Nadal, U.S ., Djokovic, Soccer, Melbourne Park, Thomson Locations: Serbian, Paris, Kosovo

☆ Dispute Erupts Over Former Zappos CEO Tony Hsieh’s Happiness Brand
▼ + stars: | 2023-06-09 | by ( Katherine Sayre | ) www.wsj.com time to read: 1 min

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/dispute-erupts-over-former-zappos-ceo-tony-hsiehs-happiness-brand-aa0cc2a9

Persons: Dow Jones

☆ ASCO conference will put the focus on the fight against cancer. These stocks are in the spotlight
▼ + stars: | 2023-05-28 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +9 min

Developments in cancer research will be in the spotlight as the American Society of Clinical Oncology hosts the world's biggest cancer research conference in Chicago, starting Thursday. The pair has already has won regulatory approval for Enhertu for metastatic HER2-low breast cancer, but the companies are also studying its use in a variety other HER2 tumors in breast cancers. Lilly's drug, Verzenio, is used in high-risk patients with HR-positive HER2-negative breast cancer that is more likely to reoccur and has already breached the patient's lymph nodes. In a research note earlier this month, Guggenheim analyst Seamus Fernandez said Kisqali is already taking market share from Pfizer's Ibrance in metastatic breast cancer. Merck's Keytruda is also being watched for what benefits it could offer early-stage lung cancer patients .

☆ Webb telescope spots water in rare comet
▼ + stars: | 2023-05-15 | by ( Ashley Strickland | ) edition.cnn.com time to read: +5 min

CNN —Astronomers used the James Webb Space Telescope to observe a rare comet in our solar system, making a long-awaited scientific breakthrough and stumbling across another mystery at the same time. For the first time, water was detected in a main belt comet, or a comet located in the main asteroid belt between the orbits of Mars and Jupiter. The space observatory detected water vapor around Comet Read, which suggests that water ice can be preserved in a warmer part of the solar system. It’s possible that the warmer temperatures of the main asteroid belt cause Comet Read to lose its carbon dioxide over time, the researchers said. Comet Read might have also formed in a warmer pocket of the solar system without carbon dioxide, Kelley said.

May 1 (Reuters) - Longtime Kleiner Perkins partner Wen Hsieh is leaving the Silicon Valley venture capital establishment to start a fund with backing from the firm and Taiwanese chipmaker TSMC (2330.TW), sources told Reuters. Hsieh is in advanced talks to raise $200 million from limited partners including Kleiner Perkins and TSMC for the new fund called Matter Ventures. A Kleiner Perkins spokesperson confirmed Hsieh's departure and the firm's participation in the fund. Hsieh, with two PhDs from the California Institute of Technology, has worked at Kleiner Perkins for 17 years, leading investments in Chinese drone maker DJI and 3D printing company Desktop Medal (DM.N). He will remain on the boards of companies he invested in at Kleiner Perkins, including orthodontic brackets maker LightForce.

Search resuls for: "Hsieh"

25 mentions found